Zahlungen für Gesundheit und Wellness für Pharmazeutika.
Pharmaunternehmen benötigen eine sichere, konforme Zahlungsinfrastruktur. Cardflo liefert eine regulierte Zahlungsorchestrierung mit spezialisiertem Acquiring, robusten Betrugskontrollen und auditfähiger Berichterstattung für den Verkauf von verschreibungspflichtigen Medikamenten und Gesundheitsprodukten.
- Branche
- Pharmazeutika
- Kategorie
- Gesundheit
- Cardflo Unterstützung
- Ja
Der Überblick
Pharmaceutical payment processing involves complex coordination between regulatory frameworks, merchant category code (MCC) assignment, and risk management. Transactions typically fall under MCC 5912 for retail pharmacies or specialised codes for wholesale and telepharmacy.
These businesses require acquirers that accept the inherent risks of dealing with prescription-only medicines (POM), over-the-counter products, and controlled substances.
The payment stack must integrate age verification and prescriber validation to remain compliant with the Medicines and Healthcare products Regulatory Agency (MHRA) or the Food and Drug Administration (FDA).
Furthermore, data security must extend beyond PCI DSS to align with health-specific data privacy mandates such as HIPAA in the United States or the Data Protection Act in the United Kingdom.
Robust gateway infrastructure ensures that every authorisation undergoes rigorous fraud screening, including 3D Secure 2. 2 (3DS) and Address Verification Service (AVS) checks, to mitigate the risk of illegal distribution and representment challenges.
Wie es funktioniert
Merchant Onboarding and KYB
The process begins with rigorous Know Your Business (KYB) checks. Acquirers evaluate pharmacy licences, DEA registrations, or MHRA certifications.
This due diligence ensures the merchant is authorised to dispense specific schedules of medication. The acquirer assigns the appropriate MCC, such as 5912, based on the merchant's specific licence and delivery model.
Checkout and Age Verification
At the point of sale, the gateway triggers third-party age and identity verification services. This happens before the authorisation request is sent to the issuer.
If the consumer fails these checks, the transaction is terminated to ensure compliance with laws governing the sale of restricted health products.
Authorisation and Fraud Screening
Transaction data is routed through a fraud engine that prioritises SCA compliance and 3DS protocols. The system analyses factors like BIN location, IP address, and AVS data.
Merchants often require network tokenisation to secure cardholder data for recurring prescriptions while reducing the scope of PCI DSS audits.
Settlement and Audit Reporting
After successful authorisation and capture, funds are settled into the merchant account, often with a rolling reserve to manage the higher chargeback risks in the sector.
Detailed line-item reports are generated, allowing for reconciliation between the payment gateway and the pharmacy management software for regulatory auditing.
Warum es wichtig ist
Risk Mitigation and Compliance
Operating in the pharmaceutical sector without specialised payment infrastructure leads to high decline rates and potential account terminations. Card schemes view pharmacies as high-risk due to regulatory volatility.
Using specific MCC 5912 acquiring pathways and robust 3DS implementations protects the merchant's ability to process payments while satisfying the legal requirements of health regulators and card brands.
Operational Continuity for Patients
For patients relying on chronic medication, payment failure can lead to health risks. Payment orchestration allows for smart routing and account updaters, ensuring that recurring prescription renewals are not interrupted by expired cards or false-positive fraud declines.
This stability is critical for maintainance therapy and B2B wholesale supply chains where large-value transactions must clear reliably.
Regulatorische Hinweise
Card Scheme Pharmacy Monitoring
Visa and Mastercard operate specific monitoring programmes for pharmacies. Merchants must register through their acquirers and may be subject to additional fees.
Failure to comply with scheme rules regarding illegal drug sales or cross-border shipping can result in immediate termination of processing privileges and inclusion on the MATCH list.
PSD2 and Medical MITs
Under PSD2, recurring prescription payments are treated as Merchant-Initiated Transactions (MITs). These require an initial transaction with Strong Customer Authentication.
Subsequent payments can be processed without SCA, provided they are correctly flagged in the authorisation message, ensuring uninterrupted service for long-term health management.
Anwendungsfälle
Online Pharmacy Portals
E-commerce platforms dispensing prescription-only medicines need integrated prescriber validation and identity checks. They require secure vaults for storing patient payment methods for repeat prescriptions.
Wholesale Health Distribution
B2B distributors handling bulk pharmaceutical supplies require high-limit processing and multi-currency settlement capabilities to manage cross-border transacting between manufacturers and retail chains.
Telehealth and Consultation Services
Services combining a medical consultation with a prescription require a split-payment or secondary authorisation model to separate the professional service fee from the drug dispensing cost.
In Zahlen
Most card schemes require pharmacies to maintain a chargeback-to-transaction ratio below this threshold to avoid entering high-risk monitoring programmes.
Typical improvement observed when pharmacies switch from generic gateways to those using account updaters and high-risk-optimised routing.
Standard duration for a 3DS2 challenge, indicating the necessity of low-latency gateway infrastructure to prevent patient checkout abandonment.
Verwandte Begriffe
Book a scoping call to see how Cardflo would set you up.
Was ist enthalten.
- Konforme Zahlungsabwicklung für regulierte Gesundheitsprodukte
- Spezialisierte Acquirer-Beziehungen für Pharmahändler
- Fortschrittliche Betrugsprävention und 3DS-Authentifizierung
- Sichere Tokenisierung und PCI DSS Level 1 Infrastruktur
- Multi-Währungs-Unterstützung für den internationalen Vertrieb
- Detaillierte Analysen und auditfähige Berichterstattung
- Account updater services to maintain continuity for subscription-based wellness and pharmacy plans.
- Multi-currency settlement options to facilitate cross-border B2B pharmaceutical trade and distribution.
- Advanced dispute management with templates tailored to pharmaceutical regulatory requirements and proof-of-delivery.
- High-capacity processing for large-ticket wholesale transactions with specialised risk profiling and monitoring.
Talk to an acquiring specialist about your MID setup.
Häufig gestellte Fragen.
Ist Cardflo konform mit den Zahlungsvorschriften für Pharmazeutika?
Cardflo arbeitet mit Acquirern zusammen, die Erfahrung in regulierten Gesundheitssektoren haben. Unsere Infrastruktur unterstützt die Compliance-Anforderungen für den Verkauf von verschreibungspflichtigen Medikamenten und Pharmazeutika.
Wie verwaltet Cardflo das Betrugsrisiko für Pharmaverkäufe?
Cardflo setzt fortschrittliche Betrugserkennung, 3DS-Optimierung und Transaktionsüberwachung ein, die auf Pharmahändler zugeschnitten sind. Dies reduziert Rückbuchungen und schützt den Umsatz.
Kann Cardflo den internationalen Vertrieb von Pharmazeutika unterstützen?
Ja, Cardflo bietet Multi-Währungs-Abwicklung und globales Acquiring, was es Pharmaunternehmen ermöglicht, Zahlungen auf internationalen Märkten effizient zu akzeptieren.
What is the role of an account updater in pharmacy subscriptions?
Many pharmacies move to a subscription model for chronic medications. If a patient's card expires or is replaced, the payment will fail, leading to a disruption in care.
An account updater service automatically communicates with the card schemes to retrieve new card details before the next billing cycle. This ensures the Merchant-Initiated Transaction (MIT) is successful, reducing dunning efforts and ensuring the patient receives their medication without delay.
How does tokenisation help with PCI DSS compliance for pharmacies?
Tokenisation replaces sensitive primary account numbers (PAN) with non-sensitive digital tokens. For pharmacies, this means that patient payment data is not stored on their local servers, significantly reducing the scope of their PCI DSS audit.
Since health organisations are also subject to strict data privacy laws like HIPAA, tokenisation adds a layer of security that ensures card data is decoupled from patient health records, minimising the impact of potential data breaches.
What documentation is required for a pharmacy to obtain a MID?
To obtain a Merchant Identification Number (MID) in the pharmaceutical sector, a business must typically provide its pharmacy licence, the pharmacist’s professional certification, and proof of registration with national bodies like the GPhC in the UK.
Acquirers also review the website’s terms and conditions, refund policies, and the presence of required regulatory stamps. A review of the supply chain and proof of partnership with licensed distributors is often necessary to satisfy AML and KYB requirements.
Bereit für Geschwindigkeit?
Erzählen Sie uns von Ihrem Unternehmen. Wir vermitteln Ihnen die passenden Acquirer-Partner und den richtigen Weg, normalerweise innerhalb einer Woche.